Clinical Trials List
2021-07-01 - 2024-07-26
Phase II
Not yet recruiting2
Recruiting3
ICD-10C22.9
Malignant neoplasm of liver, not specified as primary or secondary
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9155.2
Malignant neoplasm of liver, not specified as primary or secondary
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Hung-Chih Hsu Division of Hematology & Oncology
- Tse-Ching Chen Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
- 呂嘉偉 Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- Chen-Chun Lin Division of Hematology & Oncology
- 徐執中 Division of Hematology & Oncology
- Cheng-Lung Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Rheun-Chuan Lee Division of Radiology
- Ming-Huang Chen Division of Hematology & Oncology
- Chung-Pin Li Division of General Internal Medicine
- Yi-Hsiang Huang Division of General Internal Medicine
- Yee Chao Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chiu Hung Chiu Division of General Internal Medicine
- 邱彥程 Division of General Internal Medicine
- 顏志傑 Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- Chien-Jui Huang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ann-Lii Cheng Division of General Internal Medicine
- YU-YUN SHAO Division of Hematology & Oncology
- Chien-Hung Chen Division of General Internal Medicine
- 廖思涵 Division of General Internal Medicine
- Chih-Hung Hsu Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 蘇東弘 Division of General Internal Medicine
- Shih-Jer Hsu Division of General Internal Medicine
- 林宗哲 Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
- 楊宏志 Division of General Internal Medicine
- 林昭文 Division of Ophthalmology
- Ying-Chun Shen Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- 曾岱宗 未分科
- 洪俊銘 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
90 participants
